Detalles de la búsqueda
1.
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 25(6): 720-730, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740030
2.
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-Pacific.
Int J Urol
; 31(1): 32-38, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795933
3.
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territories.
Int J Urol
; 31(1): 64-71, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37800879
4.
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
J Urol
; 209(1): 131-139, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36250938
5.
Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study.
BMC Cancer
; 22(1): 1163, 2022 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357914
6.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Lancet Oncol
; 22(7): 919-930, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051177
7.
Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment.
Int J Mol Sci
; 22(17)2021 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34502435
8.
Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1.
Prostate
; 80(6): 453-462, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32134535
9.
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis.
BMC Cancer
; 19(1): 688, 2019 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307432
10.
Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
BMC Cancer
; 18(1): 617, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29855390
11.
The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients.
Jpn J Clin Oncol
; 48(9): 835-840, 2018 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053128
12.
Hand-Holding during Cystoscopy Decreases Patient Anxiety, Pain, and Dissatisfaction: A Pilot Randomized Controlled Trial.
Urol Int
; 100(2): 222-227, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29275402
13.
The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: a retrospective comparison study.
Jpn J Clin Oncol
; 47(9): 876-882, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28637282
14.
Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.
J Korean Med Sci
; 32(2): 377-381, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049253
15.
Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.
Histopathology
; 68(5): 673-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272590
16.
A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy.
BMC Cancer
; 16: 577, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27484254
17.
Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
World J Surg Oncol
; 14(1): 270, 2016 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27765044
18.
The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer.
BMC Urol
; 15: 82, 2015 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26269129
19.
P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
J Korean Med Sci
; 30(3): 308-16, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25729255
20.
Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
J Korean Med Sci
; 30(8): 1150-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26240494